Can you use GLP1-RAs while nursing
For patients with non-alcoholic fatty liver disease or non-alcoholic steatohepatitis, tirzepatide represents one of the most effective interventions currently available
Manag Care 22:7172 Niessl C, Boulesteix AL, Oh J, Palm K, Schlingmann P, Wygoda S, Haffner D, Wuhl E, Tonshoff B, Buescher A, Billing H, Hoppe B, Zirngibl M, Kettwig M, Moeller K, Acham-Roschitz B, Arbeiter K, Bald M, Benz M, Galiano M, John-Kroegel U, Klaus G, Marx-Berger D, Moser K, Mueller D, Patzer L, Pohl M, Seitz B, Treikauskas U, von Vigier RO, Gahl WA, Hohenfellner K (2022) Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis
Patients often experience mistrust due to concerns about side effects and fear of judgment
This dual effect results in reduced adiposity and improved fat utilization for energy, which has led researchers to explore its role as a metabolic regulator rather than a simple weight loss agent